查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1629876

全球線上血液監測設備市場 - 2025-2033

Global In-Line Blood Monitoring Devices Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 179 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024年，全球線上血液監測設備市場達到100,630.41萬美元，預計2033年將達到317,891.08萬美元，2025-2033年預測期間複合年成長率為11.6%。

線上血液監測設備是用於連續測量和即時評估患者血液的各種關鍵參數的醫療儀器，通常在外科手術、重症監護或體外治療（如心肺旁路、透析或 ECMO）期間使用。這些設備直接整合到血液循環路徑中，無需重複採血即可進行非侵入性或微創監測。

對線上血液監測設備的需求正在經歷顯著成長，這歸因於諸如需要體外循環的外科手術的增加以及移植等關鍵心血管手術的增加等因素。例如，根據麻省總醫院布里格姆組織的數據，美國每年進行超過 90 萬例心臟手術，包括冠狀動脈繞道手術，世界各地進行的手術數量甚至更多。心臟手術是針對心臟及其大血管（包括肺動脈和主動脈）進行的。

此外，據 ScienceDirect 稱，手術最近被認為是國家衛生系統不可或缺的一部分，但仍有約 50 億人在需要時無法及時獲得安全且負擔得起的手術護理。每年有超過1700 萬人死於手術可預防的疾病，而每年進行的3.13 億例手術干預中，只有6% 發生在世界上最貧困的三分之一人口中，而這些人對手術護理的需求最高。這些不斷增加的外科手術增加了對線上血液監測設備市場的需求。

市場動態：

驅動程式和限制

心血管疾病和危重疾病的盛行率不斷增加

心血管疾病和敗血症、中風和呼吸衰竭等危重疾病的盛行率不斷上升，大大推動了線上血液監測設備市場的成長。這些情況需要持續即時監測關鍵血液參數，例如氧氣水平、血氣、電解質和血紅蛋白。線上血液監測設備對於提供連續、非侵入性和準確的評估以最佳化重症監護病房 (ICU)、手術室和急診護理機構的患者護理至關重要。

例如，根據世界衛生組織 (WHO) 的統計，心血管疾病 (CVD) 是全球主要死亡原因，估計每年奪走 1,790 萬人的生命。心血管死亡人數的上升刺激了在冠狀動脈繞道、心臟移植和其他心血管手術等高風險手術中對高階監測的需求。

線上血液監測設備，特別是在心臟手術中，可以即時追蹤血氧飽和度、pH 水平和二氧化碳濃度等參數，這對於在這些複雜手術過程中管理患者的穩定性至關重要。

全球高血壓和其他心血管疾病危險因子的增加與持續監測血液參數以預防治療期間或術後恢復期間併發症的需求日益增加直接相關。

例如，根據世界衛生組織的數據，全球估計有 12.8 億 30-79 歲的成年人患有高血壓，其中大多數（三分之二）生活在低收入和中等收入國家。據估計，46% 的成年人高血壓患者並不知道自己患有這種疾病。不到一半（42%）的成年人高血壓得到診斷和治療。大約五分之一的成年人（21%）患有高血壓，其病情得到控制。

與現有系統整合的複雜性

與現有醫療保健系統整合的複雜性是阻礙全球線上血液監測設備市場成長的關鍵挑戰。雖然這些設備提供了連續即時監測的先進功能，但將它們與醫院資訊系統 (HIS)、電子健康記錄 (EHR) 和其他臨床基礎設施整合仍然是一個重大障礙。

許多醫療機構仍然依賴舊系統，這些系統無法與現代監控設備無縫連接。較舊的 EHR 系統或醫院管理軟體通常缺乏與較新的線上監控技術的兼容性。

醫療保健 IT 新聞的一項研究強調，80% 的醫療保健提供者仍然面臨將更新的診斷技術整合到現有基礎設施中的問題。線上血液監測設備需要與現有平台整合以進行資料傳輸和分析，但這些過時的系統可能會導致延遲、錯誤甚至資料遺失。

將連續性血液監測設備與醫院 IT 系統整合會帶來嚴重的資料安全和隱私問題。例如，根據 HIPAA 雜誌報導，2023 年 8 月，發現有 2,300 萬筆醫療記錄被洩露。在過去 12 個月中，平均每月有 9,989,003 筆醫療記錄被洩露。

目錄

第1章：市場介紹和範圍

  • 報告的目標
  • 報告範圍和定義
  • 報告範圍

第 2 章：高階主管見解與要點

  • 市場亮點和戰略要點
  • 主要趨勢和未來預測
  • 按模態分類的片段
  • 按產品分類
  • 按應用程式片段
  • 按地區分類的片段

第 3 章：動力學

  • 影響因素
    • 促進要素
      • 心血管疾病和危重疾病的盛行率不斷增加
      • 越來越多的外科手術需要體外循環
    • 限制
      • 與現有系統整合的複雜性
    • 機會
    • 影響分析

第 4 章：策略洞察與產業展望

  • 市場領導者和先驅
    • 新興先鋒和傑出參與者
    • 擁有最大銷售品牌的知名領導者
    • 擁有成熟產品的市場領導者
  • 新興新創企業和關鍵創新者
  • CXO 觀點
  • 最新進展和突破
  • 案例研究/正在進行的研究
  • 監管和報銷情況
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 波特五力分析
  • 供應鏈分析
  • 專利分析
  • SWOT分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析：最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態

第 5 章：按模式分類的線上血液監測設備市場

  • 桌上型
  • 便攜的

第 6 章： 線上血液監測設備市場（按產品）

  • 線上血液監測設備
  • 耗材

第 7 章：線上血液監測設備市場（按應用）

  • 心肺繞道手術
  • 移植程式
  • 先天性心臟病手術
  • ECMO
  • 其他

第 8 章：線上血液監測設備市場，按區域市場分析和成長機會

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第 9 章：競爭格局與市場定位

  • 競爭概況和主要市場參與者
  • 市佔率分析與定位矩陣
  • 策略夥伴關係、併購
  • 產品組合和創新的主要發展
  • 公司基準化分析

第 10 章：公司簡介

  • Terumo Corporation
    • 公司概況
    • 產品組合和描述
    • 財務概覽
    • 主要進展
    • SWOT分析
  • LivaNova PLC
  • Eurosets Srl
  • Spectrum Medical Ltd.

第 11 章：假設與研究方法

  • 資料收集方法
  • 數據三角測量
  • 預測技術
  • 數據驗證和確認

第 12 章：附錄

簡介目錄
Product Code: MD8906

The global In-line blood monitoring devices market reached US$ 100,630.41 thousand in 2024 and is expected to reach US$ 317,891.08 thousand by 2033, growing at a CAGR of 11.6% during the forecast period 2025-2033.

In-line blood monitoring devices are medical instruments used to continuously measure and assess various critical parameters of a patient's blood in real-time, typically during surgical procedures, intensive care or extracorporeal treatments such as cardiopulmonary bypass, dialysis, or ECMO (Extracorporeal Membrane Oxygenation). These devices are integrated directly into the blood circulation pathway, allowing for non-invasive or minimally invasive monitoring without requiring repeated blood sampling.

The demand for In-line blood monitoring devices is experiencing significant growth, which is attributed to factors such as growing surgical procedures requiring extracorporeal circulation and the growing critical cardiovascular procedures such as transplantations. For instance, according to the Mass General Brigham Organization, more than 900,000 cardiac surgeries, including coronary bypass surgeries, are performed in the U.S. every year, with even more taking place throughout the world. Cardiac surgery is performed on the heart and its large blood vessels, including the pulmonary arteries and the aorta.

Additionally, according to ScienceDirect, surgery has recently been recognized as an integral part of national health systems, yet approximately 5 billion people remain without timely access to safe and affordable surgical care when needed. More than 17 million people die of surgically preventable conditions every year, and only 6% of the 313 million surgical interventions taking place every year occur in the poorest one-third of the world's population, in whom the need for surgical care is highest. These rising surgical procedures increase the demand for in-line blood monitoring devices market.

Market Dynamics: Drivers & Restraints

Increasing prevalence of cardiovascular and critical conditions

The increasing prevalence of cardiovascular diseases and critical conditions like sepsis, stroke and respiratory failure is significantly driving the growth of the In-line blood monitoring devices market. These conditions require constant, real-time monitoring of critical blood parameters, such as oxygen levels, blood gases, electrolytes and hemoglobin. In-line blood monitoring devices are critical in providing continuous, non-invasive and accurate assessments to optimize patient care in intensive care units (ICUs), operating rooms and emergency care settings.

For instance, according to the World Health Organization (WHO), Cardiovascular diseases (CVDs) are the leading cause of death globally, taking an estimated 17.9 million lives each year. This rising cardiovascular deaths has spurred the demand for advanced monitoring during high-risk procedures like coronary artery bypass, heart transplants and other cardiovascular surgeries.

In-line blood monitoring devices, particularly in cardiac surgeries, enable real-time tracking of parameters such as blood oxygen saturation, pH levels and carbon dioxide concentrations, essential for managing patient stability during these complex procedures.

The global rise in hypertension and other risk factors for cardiovascular diseases directly correlates to an increasing need for continuous monitoring of blood parameters to prevent complications during treatments or post-surgical recovery.

For instance, according to the World Health Organization, an estimated 1.28 billion adults aged 30-79 years worldwide have hypertension, most (two-thirds) living in low- and middle-income countries. An estimated 46% of adults with hypertension are unaware that they have the condition. Less than half of adults (42%) with hypertension are diagnosed and treated. Approximately 1 in 5 adults (21%) with hypertension have it under control.

Complexity of integration with existing systems

The complexity of integration with existing healthcare systems is a key challenge hampering the growth of the global In-line blood monitoring devices market. While these devices offer advanced capabilities for continuous, real-time monitoring, integrating them with hospital information systems (HIS), electronic health records (EHR) and other clinical infrastructure remains a significant hurdle.

Many healthcare facilities still rely on legacy systems that were not designed to interface seamlessly with modern monitoring devices. Older EHR systems or hospital management software often lack compatibility with newer in-line monitoring technologies.

A study by Healthcare IT News highlighted that 80% of healthcare providers still face issues integrating newer diagnostic technologies into their existing infrastructure. In-line blood monitoring devices need to be integrated with existing platforms for data transmission and analysis, but these outdated systems can cause delays, errors or even data loss.

Integrating continuous blood monitoring devices with hospital IT systems raises significant data security and privacy issues. For instance, according to the HIPAA Journal, in August 2023, 23 million breached healthcare records were noticed. Over the past 12 months, an average of 9,989,003 healthcare records were breached each month.

Segment Analysis

The global In-line blood monitoring devices market is segmented based on modality, product, application and region.

Product:

The In-line blood monitoring devices segment is expected to dominate the market

The In-line blood monitoring devices segment is expected to dominate the global market. The In-line blood monitoring devices are crucial for diagnosing various medical conditions, including respiratory failure, metabolic disorders and conditions affecting oxygenation. Healthcare providers often utilize this during surgeries by integrating with heart-lung machines to make timely decisions regarding patient care. By assessing parameters such as partial pressures of oxygen (PaO2), carbon dioxide (PaCO2) and bicarbonate levels, clinicians can determine the adequacy of ventilation and oxygenation, guiding interventions like oxygen therapy or mechanical ventilation.

The companies are developing advanced in-line blood monitoring devices that meet the safety and regulatory standards that are set by the regulatory bodies. For instance, in March 2024, Terumo Cardiovascular received the FDA 510(k) clearance for its next-generation CDI OneView monitoring system. Terumo's CDI systems display patient parameters during cardiopulmonary bypass surgery to support perfusion safety and improve patient outcomes. This new CDI OneView system measures or displays up to 22 vital patient parameters, including oxygen delivery, cardiac index, area under the indexed oxygen delivery curve, oxygen extraction ratio and measured flow.

Additionally in August 2024, LivaNova received the FDA 510(k) clearance and CE mark for its Essenz in-line blood monitor. Essenz ILBM provides accurate and continuous measurement of essential blood parameters throughout cardiopulmonary bypass (CPB) procedures, according to LivaNova. It integrates into the next-generation Essenz perfusion system. Essenz enables perfusionists to access and manage reliable blood parameters directly from the system's cockpit. It eliminates the need for additional monitors or holders.

Geographical Analysis

North America is expected to hold a significant position in the In-line blood monitoring devices market share

North America is expected to hold the largest market share in the global In-line blood monitoring devices market. The increasing prevalence of chronic diseases and the rising number of cardiac surgeries driving the in-line blood monitoring devices market. The use of in-line monitoring devices in operating rooms for cardiac bypass surgeries is a crucial factor in the healthcare landscape of North America. With a substantial number of Coronary Artery Bypass Grafting (CABG) procedures performed annually, the demand for advanced monitoring technologies is essential for ensuring patient safety and enhancing surgical outcomes.

For instance, as per ScienceDirect research in June 2024, the average total cardiac surgical volume across 24 countries with available data was 123.2 surgeries per 100,000 population per year. This figure varies significantly by country, with South Korea reporting a low of 27.3 surgeries per 100,000 and the United States exhibiting the highest rate at 271.5 surgeries per 100,000. This increasing surgery number demands in-line blood monitoring devices in the U.S. market.

The increasing prevalence of cardiovascular diseases is driving the need for advanced monitoring devices during surgical interventions. As a greater number of patients undergo surgeries that involve cardiopulmonary bypass, there is a demand for dependable in-line blood monitoring devices.

For instance, according to the Centers for Disease Control and Prevention (CDC), cardiovascular disease remains the leading cause of death for both men and women across various racial and ethnic groups in the United States. In 2022, around 702,880 individuals lost their lives to heart disease, which translates to approximately 1 in every 5 deaths. With a person succumbing to cardiovascular disease every 33 seconds, there is an urgent need for prompt and precise medical interventions in clinical environments. The implementation of continuous blood monitoring can significantly enhance patient outcomes during critical surgical procedures.

Asia-Pacific is growing at the fastest pace in the In-line blood monitoring devices market

The Asia-Pacific region is experiencing the fastest growth in the In-line blood monitoring devices market. The increasing number of bypass surgeries and heart-lung transplants in the Asia-Pacific region is a significant driving factor for the in-line monitoring devices market indicating an increasing demand for surgical interventions aimed at treating severe cardiovascular diseases. As more patients undergo these procedures, there is a corresponding need for effective in-line monitoring devices that can continuously track vital signs, including heart rate, blood pressure, oxygen saturation, and other critical parameters during surgery.

The increase in Coronary Artery Bypass Grafting (CABG) procedures in India signifies a growing demand for effective cardiac interventions. As more patients undergo CABG, the need for reliable in-line blood monitoring devices becomes crucial to ensure patient safety and optimize surgical outcomes. Continuous monitoring of vital parameters such as blood pressure, heart rate, and oxygen saturation is essential during these complex surgeries.

For instance, according to the Times of India (TOI), the increase in bypass surgeries among patients in their early to mid-30s by 30% over the past decade, with an annual rise of 5%, is a significant driving factor for the in-line blood monitoring devices market. This trend reflects a concerning shift in cardiovascular health, indicating that heart attacks and related diseases are becoming more prevalent in younger individuals.

Additionally, according to the Journal of the Practice of Cardiovascular Sciences, in India, 1,328 heart transplants, 475 lung transplants, 128 Left Ventricular Assist Device (LVAD) implants, and 61 lung transplants for COVID-19 lung disease completed by March 2023, highlights significant advancements in the field of organ transplantation. The annual figures show a steady number of procedures, with 129 lung transplants performed in 2023 and 62 in 2024 up to July, alongside 102 heart transplants in 2023 and 62 in 2024 until July. This upward trend in complex surgical procedures is a crucial driver for the inline monitoring devices market in the region.

Competitive Landscape

The major global players in the In-line blood monitoring devices market include Terumo Corporation, LivaNova PLC, Eurosets S.r.l. and Spectrum Medical Ltd.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global In-line blood monitoring devices market report delivers a detailed analysis with 44 key tables, more than 48 visually impactful figures, and 179 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Modality
  • 2.4. Snippet by Product
  • 2.5. Snippet by Application
  • 2.6. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Increasing Prevalence of Cardiovascular and Critical Conditions
      • 3.1.1.2. Growing Surgical Procedures Requiring Extracorporeal Circulation
    • 3.1.2. Restraints
      • 3.1.2.1. Complexity of Integration with Existing Systems
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. Emerging Startups and Key Innovators
  • 4.3. CXO Perspectives
  • 4.4. Latest Developments and Breakthroughs
  • 4.5. Case Studies/Ongoing Research
  • 4.6. Regulatory and Reimbursement Landscape
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia Pacific
    • 4.6.4. Latin America
    • 4.6.5. Middle East & Africa
  • 4.7. Porter's Five Force Analysis
  • 4.8. Supply Chain Analysis
  • 4.9. Patent Analysis
  • 4.10. SWOT Analysis
  • 4.11. Unmet Needs and Gaps
  • 4.12. Recommended Strategies for Market Entry and Expansion
  • 4.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.14. Pricing Analysis and Price Dynamics

5. In-Line Blood Monitoring Devices Market, By Modality

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 5.1.2. Market Attractiveness Index, By Modality
  • 5.2. Bench Top*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Portable

6. In-Line Blood Monitoring Devices Market, By Product

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 6.1.2. Market Attractiveness Index, By Product
  • 6.2. In-Line Blood Monitoring Devices*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Consumables

7. In-Line Blood Monitoring Devices Market, By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Cardiopulmonary Bypass Procedures*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Transplant Procedures
  • 7.4. Congenital Heart Procedures
  • 7.5. ECMO
  • 7.6. Others

8. In-Line Blood Monitoring Devices Market, By Regional Market Analysis and Growth Opportunities

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 8.1.2. Market Attractiveness Index, By Region
  • 8.2. North America
    • 8.2.1. Introduction
    • 8.2.2. Key Region-Specific Dynamics
    • 8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.2.6.1. U.S.
      • 8.2.6.2. Canada
      • 8.2.6.3. Mexico
  • 8.3. Europe
    • 8.3.1. Introduction
    • 8.3.2. Key Region-Specific Dynamics
    • 8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.3.6.1. Germany
      • 8.3.6.2. U.K.
      • 8.3.6.3. France
      • 8.3.6.4. Spain
      • 8.3.6.5. Italy
      • 8.3.6.6. Rest of Europe
  • 8.4. South America
    • 8.4.1. Introduction
    • 8.4.2. Key Region-Specific Dynamics
    • 8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.4.6.1. Brazil
      • 8.4.6.2. Argentina
      • 8.4.6.3. Rest of South America
  • 8.5. Asia-Pacific
    • 8.5.1. Introduction
    • 8.5.2. Key Region-Specific Dynamics
    • 8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.5.6.1. China
      • 8.5.6.2. India
      • 8.5.6.3. Japan
      • 8.5.6.4. South Korea
      • 8.5.6.5. Rest of Asia-Pacific
  • 8.6. Middle East and Africa
    • 8.6.1. Introduction
    • 8.6.2. Key Region-Specific Dynamics
    • 8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 8.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

9. Competitive Landscape and Market Positioning

  • 9.1. Competitive Overview and Key Market Players
  • 9.2. Market Share Analysis and Positioning Matrix
  • 9.3. Strategic Partnerships, Mergers & Acquisitions
  • 9.4. Key Developments in Product Portfolios and Innovations
  • 9.5. Company Benchmarking

10. Company Profiles

  • 10.1. Terumo Corporation*
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio and Description
    • 10.1.3. Financial Overview
    • 10.1.4. Key Developments
    • 10.1.5. SWOT Analysis
  • 10.2. LivaNova PLC
  • 10.3. Eurosets S.r.l.
  • 10.4. Spectrum Medical Ltd.

LIST NOT EXHAUSTIVE

11. Assumption and Research Methodology

  • 11.1. Data Collection Methods
  • 11.2. Data Triangulation
  • 11.3. Forecasting Techniques
  • 11.4. Data Verification and Validation

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us